Regulatory

Pic:getty/moyostudio

Syner-G Biopharma Group acquires Impact

By Rachel Arthur

Syner-G BioPharma Group, a provider of Chemistry, Manufacturing, and Controls (CMC) technical, regulatory, and compliance consulting services to the pharmaceutical and biotechnology industry, has acquired Impact Pharmaceutical Services.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All